Drug Shortage Report for FOQUEST

Last updated on 2024-11-26 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-12-06
Actual end date 2024-11-25
Shortage status Resolved
Updated date 2024-11-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v177 2024-11-26 English Compare
v176 2024-11-25 French Compare
v175 2024-11-25 English Compare
v174 2024-11-07 French Compare
v173 2024-11-07 English Compare
v172 2024-10-29 French Compare
v171 2024-10-29 English Compare
v170 2024-10-15 French Compare
v169 2024-10-15 English Compare
v168 2024-09-16 French Compare
v167 2024-09-16 English Compare
v166 2024-06-24 French Compare
v165 2024-06-24 English Compare
v164 2024-05-31 French Compare
v163 2024-05-31 English Compare
v162 2024-05-24 French Compare
v161 2024-05-24 English Compare
v160 2024-05-13 French Compare
v159 2024-05-13 English Compare
v158 2024-05-13 English Compare

Showing 1 to 20 of 177